<DOC>
	<DOC>NCT02730468</DOC>
	<brief_summary>The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.</brief_summary>
	<brief_title>SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>1. 18 years or older 2. Meet 2 of 4 sepsis criteria 1. Temperature &gt; 38C or &lt; 36C 2. Heart rate &gt; 90 bpm 3. Respiratory rate &gt;20 or PaCO2 &lt;32mmHg 4. WBC &gt;12000/µL or &lt; 4000/µL or &gt; 10% bands 1. Inability to understand instructions and comply with studyrelated procedures 2. Any condition that in the opinion of the treating physician will prevent the subject from completing the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>